# Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy -

> **NCT03287375** · PHASE2 · COMPLETED · sponsor: **Michael Bau Mortensen** · enrollment: 143 (actual)

## Conditions studied

- Peritoneum; Carcinomatosis
- Peritoneal Neoplasms
- Peritoneal Metastases
- Chemotherapy Effect
- Chemotherapeutic Toxicity
- Quality of Life
- Histologic Progression

## Interventions

- **DRUG:** PIPAC

## Key facts

- **NCT ID:** NCT03287375
- **Lead sponsor:** Michael Bau Mortensen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-01
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2022-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03287375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03287375, "Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy -". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03287375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*